| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b82f96f476d23a7668947a83cdaefcc4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-465 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-2402
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y302-01022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-2465
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y302-01049
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0641
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-34 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-34 |
| filingDate |
2002-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_006fb7f2b38a78c9e336472310c931a3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77ce9bcbc796dbe7c4aa55f28e7a94ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22623893d13c2608999fd3fc0c4908fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_551a5669902fb621700b9adc3c07ff90 |
| publicationDate |
2011-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2302045-A1 |
| titleOfInvention |
Enzymatic conversion of blood group B, and AB red blood cells using an alpha-galactosidase with unique substrate specificities and kinetic properties |
| abstract |
There is disclosed a strain of prokaryotic cell capable of expressing an α-galactosidase for removing type B antigens from blood group B or AB reactive cells in blood products, wherein said α-galactosidase has the following characteristics: (i) no less than 10% activity with blood group B oligosaccharides compared to simple α-Gal monosaccharide derivatives, and (ii) active in red blood cell conversion of blood group B oligosaccharides at neutral pH. |
| priorityDate |
2001-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |